AJP - Regulatory, Integrative and Comparative Physiology, Vol 266, Issue 6 1861-R1867, Copyright © 1994 by American Physiological Society

ARTICLES

Angiotensin I is converted to angiotensin II by a serine protease in human detrusor smooth muscle

B. F. Lindberg, L. G. Nilsson, H. Hedlund, M. Stahl and K. E. Andersson
Department of Clinical Pharmacology, Lund University Hospital, Sweden.

The aim of the present study was to investigate whether a pathway for conversion of angiotensin I (ANG I) to angiotensin II (ANG II) other than that via angiotensin-converting enzyme (ACE) is present in the smooth muscle of the human detrusor. Isolated detrusor strips from 11 patients were contracted by ANG I (1 microM) in the absence or presence of enalaprilat (10 microM), soybean trypsin inhibitor (STI, 200 micrograms/ml), or both. The metabolic activity in detrusor membranes from four patients was studied separately using Hip-Gly-Gly or ANG I as a substrate, with or without various protease inhibitors. The contractile response to ANG I (1 microM) was depressed by enalaprilat from 66 +/- 22 (mean +/- SD) to 39 +/- 13% of the K+ (124 mM)-induced response (P < 0.01, n = 11), and the combination of enalaprilat and STI resulted in a further reduction in contractile amplitude to 25 +/- 14% (P < 0.01 vs. K+, and P < 0.05 vs. enalaprilat alone) and a significantly slower developing contraction with a time to peak of 3.7 +/- 1.7 vs. 1.1 +/- 0.3 min for ANG I alone (P < 0.01). In detrusor membranes, a low ACE activity, inhibitable by captopril, was demonstrated by the formation of hippuric acid (0.70 nmol.min-1.mg protein-1) from the synthetic ACE substrate, Hip-Gly-Gly. However, the conversion of ANG I (166 nmol.min-1.mg protein-1) to ANG II was not affected by ACE inhibition, while serine protease inhibitors, e.g., STI and chymostatin, completely prevented ANG II formation.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				K.-E. Andersson and A. Arner Urinary Bladder Contraction and Relaxation: Physiology and Pathophysiology Physiol Rev, July 1, 2004; 84(3): 935 - 986. [Abstract] [Full Text] [PDF]

				K. Inoue, H. Nishimura, J. Kubota, and K. Kawamura Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I Hypertension, September 1, 1999; 34(3): 525 - 530. [Abstract] [Full Text] [PDF]

				H. Nishimura, H. Buikema, O. Baltatu, D. Ganten, and H. Urata Functional evidence for alternative ANG II-forming pathways in hamster cardiovascular system Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1307 - H1312. [Abstract] [Full Text] [PDF]

				A. Wolny, J.-P. Clozel, J. Rein, P. Mory, P. Vogt, M. Turino, W. Kiowski, and W. Fischli Functional and Biochemical Analysis of Angiotensin II–Forming Pathways in the Human Heart Circ. Res., February 1, 1997; 80(2): 219 - 227. [Abstract] [Full Text]

				I. V. Yosipiv and S. S. El-Dahr Activation of Angiotensin-Generating Systems in the Developing Rat Kidney Hypertension, February 1, 1996; 27(2): 281 - 286. [Abstract] [Full Text]